Friday, September 01, 2017 11:56:08 AM
Mr. Patient’s experience with Merus should be beneficial to IPCI. We believe his first priorities will be to strengthen the balance sheet and
try to rebuild investor confidence.
Rexista-Oxycodone PDUFA date: On July 26, the FDA advisory committee meeting set the tone for this product and voted in favour of not approving the formulation with its current clinical package. The PDUFA data for IPCI’s Rexista-oxycodone is September 25, 2017 – we are expecting a complete response letter, that is, we do not expect approval at this time. IPCI needs to get out from the shadow of Rexista and refocus its pipeline.
IMPACT – Maintaining HOLD and Target Price We expect IPCI to trade at a discount to its peer Canadian specialty pharmas due to: its current revenues mix being derived from generics (not brand), lack of near term new
product launch visibility, and potential
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM